Some CD patients have variants of the ATG16L1 and Immunity-related GTPase family M Protein (IRGM) autophagy genes, implying a defective capacity to process cell degradation products as well as bacteria, and to eliminate pro-inflammatory stimuli [28]. This evidence concerns the gene IRGM and Cowden disease.